tbuckley/cabot-search huggingface dataset:
Missing Byline Author
Authors: Troyen Brennan, William Shrank
Journal: JAMA (2014)

Antonia Kwan, PhD, MRCPCH; Roshini S. Abraham, PhD; Robert Currier, PhD; Amy Brower, PhD; Karen Andruszewski, BS; Jordan K. Abbott, MD; Mei Baker, MD; Mark Ballow, MD; Louis E. Bartoshesky, MD; Vincent R. Bonagura, MD; Francisco A. Bonilla, MD, PhD; Charles Brokopp, DrPH; Edward Brooks, MD; Michele Caggana, ScD; Jocelyn Celestin, MD; Joseph A. Church, MD; Anne Marie Comeau, PhD; James A. Connelly, MD; Morton J. Cowan, MD; Charlotte Cunningham-Rundles, MD; Trivikram Dasu, PhD; Nina Dave, MD; Maria T. De La Morena, MD; Ulrich Duffner, MD; Chin-To Fong, MD; Lisa Forbes, MD; Debra Freedenberg, MD; Erwin W. Gelfand, MD; Jaime E. Hale, BS; I. Celine Hanson, MD; Beverly N. Hay, MD; Diana Hu, MD; Anthony Infante, MD, PhD; Daisy Johnson, BSN; Neena Kapoor, MD; Denise M. Kay, PhD; Donald B. Kohn, MD; Rachel Lee, PhD; Heather Lehman, MD; Zhili Lin, PhD; Fred Lorey, PhD; Aly Abdel-Mageed, MD, MBA; Adrienne Manning, BS; Sean McGhee, MD; Theodore B. Moore, MD; Stanley J. Naides, MD; Luigi D. Notarangelo, MD; Jordan S. Orange, MD; Sung-Yun Pai, MD; Matthew Porteus, MD, PhD; Ray Rodriguez, MD, JD, MPH, MBA; Neil Romberg, MD; John Routes, MD; Mary Ruehle, MS; Arye Rubenstein, MD; Carlos A. Saavedra-Matiz, MD; Ginger Scott, RN; Patricia M. Scott, MT; Elizabeth Secord, MD; Christine Seroogy, MD; William T. Shearer, MD, PhD; Subhadra Siegel, MD; Stacy K. Silvers, MD; E. Richard Stiehm, MD; Robert W. Sugerman, MD; John L. Sullivan, MD; Susan Tanksley, PhD; Millard L. Tierce IV, DO; James Verbsky, MD, PhD; Beth Vogel, MS; Rosalyn Walker, MD; Kelly Walkovich, MD; Jolan E. Walter, MD, PhD; Richard L. Wasserman, MD, PhD; Michael S. Watson, MS, PhD; Geoffrey A. Weinberg, MD; Leonard B. Weiner, MD; Heather Wood, MS; Anne B. Yates, MD; Jennifer M. Puck, MD
Acinetobacter Infection
Authors: L. Silvia Munoz-Price, Robert A. Weinstein
Journal: New England Journal of Medicine (2008)

The gram-negative coccobacillus acinetobacter, a pathogen once seen only in hot, humid climates, has become an increasingly common nosocomial problem even in temperate climates. For infections caused by multidrug-resistant isolates, antibiotic choices may be quite limited. This review summarizes the approaches to treatment and the current understanding of the ability of acinetobacter to accumulate diverse mechanisms of resistance, with the emergence of strains resistant to all commercially available antibiotics.
Conservative treatment of massive pulmonary embolism
Authors: D. A. Emanuel
Journal: JAMA (1966)

SPONTANEOUS resolution of massive pulmonary embolism has been reported.<sup>1</sup>Important questions, however, remain to be answered. Do these emboli produce a permanent change in pulmonary function and pulmonary vascular resistance? Is pulmonary embolectomy ever indicated except as a life-saving procedure? What procedures are necessary to prevent further embolization? How rapidly does resolution of. the emboli take place? It is apparent that a large body of information is a necessity before these problems can be solved. In the case to be reported the large emboli present in the main pulmonary artery and its right and left branches resolved spontaneously. Four pulmonary angiograms were performed providing adequate roentgen demonstration of the emboli and their resolution. Subsequent pulmonary-function studies failed to reveal any adverse effect of the massive emboli. <h3>Report of a Case</h3> A 40-year-old white man suffered a fracture of his left tibia and fibula on Nov 9, 1964. Seven days
AUTHORS' REPLY
Authors: M. Miller, A. Pincock
Journal: Thorax (1989)

A new method of measuring cerebral atrophy using a ratio of brain parenchyma to ventricular and subarachnoid space is described. It uses digitized brain CT. This ratio was measured prospectively on 117 consecutive elderly patients referred for evaluation of cognitive dysfunction. Diagnosis was determined by preestablished criteria and confirmed by follow-up. Despite the improved accuracy and reproducibility of this method, its ability to differentiate persons with senile dementia of the Alzheimer9s type (SDAT) from those suffering from pseudodementia was confounded by age, and was hence of limited utility. We conclude that even with sophisticated measures of cerebral atrophy, CT is unable to discriminate among common causes of cognitive dysfunction in the elderly.
Occupational Health at Home and Abroad
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE DEGREE OF D. P. H.
Journal: JAMA (1894)

TheJournalis gratified to learn that at least one medical college has already taken steps looking to the establishment of a course leading to the degree of Doctor of Public Health—as suggested editorially in these pages last month.<sup>1</sup>The institution is prosperous, well equipped and ranks in the higher class of the four-year medical schools in one of the important centers of medical education. TheJournalwill give publicity to its announcement as soon as the details of the course in sanitary science and State medicine are perfected. Meanwhile, in order tofacilitate the establishment of similar courses by other institutions, the following summary of the requirements for this degree exacted by the General Medical Council of the United Kingdom is offered. These requirements are based, as stated in the previous article, on the provisions of the Local Government Act of 1888—to-wit, that no person shall be appointed medical
ESGE Newsletter
Journal: Endoscopy (2013)

The third Quality in Endoscopy symposium concentrated on upper GI endoscopy and neoplasia. Leaders in this field alongside young rising stars from nine different countries deliberated on the most pressing and timely topics through lectures, debates, and case presentations. Vivid discussions ensued amongst the two hundred participants stemming from 34 different countries. Beside poster presentations, this year for the first time participants also submitted clinical cases and seven young participants from Russia, Portugal, Romania, Spain and Brazil presented their cases at the meeting.
DYSBASIA ANGIOSCLEROTICA.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Leonardo Da Vinci Quaderni d'Anatomia II.
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Prescribing clindamycin
Authors: D W Milligan
Journal: BMJ (1981)

globulin have a strong but not exclusive influence.' Changes in albumin have only a minor effect, but paraproteins2 and lipoproteins3 also increase plasma and serum viscosity.For these reasons estimations of plasma fibrinogen from the difference of plasma and serum viscosity are unreliable and can be wrong by as much as 100",.
Mammographic Screening
Authors: R. Don Gambrell
Journal: JAMA (1994)

<h3>To the Editor.</h3> —I read the Editorial on mammographic screening with great concern,<sup>1</sup>since I had just been heartened the day before with the new 1994 American Cancer Society cancer statistics for 1994.<sup>2</sup>For the first time in 60 years, the number of new breast cancer cases are not expected to rise in the United States in 1994: 182000 in 1994, 182 000 in 1993, and 180 000 during 1992. Breast cancer deaths have been level for the third year in a row: 46 000 in 1992,1993, and 1994. Invasive breast cancers have been steadily declining since 1988 because of increased screening mammography.<sup>3</sup>Mortality from breast cancer has leveled because of earlier diagnosis. The authors conclude, based on meta-analysis of epidemiologic studies, that screening mammography for women younger than 50 years does not reduce deaths from breast cancer. However, four of the 15 breast cancers (26.7%) diagnosed
Abstract 2219: High Dose Modified-release Nicotinic Acid Reduces Carotid Atherosclerosis: a Randomized, Placebo-controlled Magnetic Resonance Study
Authors: Justin M Lee, Matthew D Robson, Ly-Mee Yu, Cheerag C Shirodaria, Colin Cunnington, Ilias Kylintireas, Tom Bannister, Frank Wiesmann, Ashok Handa, Keith M Channon, Stefan E Neubauer, Robin P Choudhury
Journal: Circulation (2008)

Background: Large clinical outcome studies (AIM-HIGH and HPS-2THRIVE) are underway testing the strategy of adding high dose nicotinic acid (NA) to statin treatment. However, the effect of this on atherosclerosis progression is unknown. Hypothesis: Nicotinic acid 2g daily would reduce change in carotid wall area, assessed by MRI, compared to placebo. Methods: We performed a double-blind randomized placebo-controlled study of 2g once daily modified release NA added to background statin therapy in 71 patients with low HDL-C &lt;40 mg/dL and either known coronary heart disease with type 2 diabetes mellitus or carotid / peripheral atherosclerosis The pre-specified primary end point was the change in carotid artery wall area, assessed by MRI, after 1 year. We compared the treatment effect using a mixed effect model adjusting for baseline covariates. Results: 22/35 NA and 29/36 placebo patients completed MRI at all time points. Baseline characteristics were similar. In the NA treated group, HDL-C increased 23% (39±6 to 48±7 mg/dL), and LDL-C decreased 19% (85±23 to 69±21 mg/dL). At 12 months, the NA group had a significantly higher reduction in carotid wall area compared to placebo (adjusted treatment difference [95% CI] = −1.64 mm 2 [−3.12, −0.16]; P=0.03). Median (IQR) change in carotid wall area was −1.42 mm 2 (−2.65, 0.79) for NA and 0.47 mm 2 (−0.97, 2.59) for placebo. At 12 months the change in carotid plaque index (calculated by the recognised method of normalising wall area to total vessel area) was also reduced compared to placebo (treatment difference −0.016 [−0.03, −0.0022]; P = 0.02). Even as early as six months, although there was no treatment difference for change in absolute carotid wall area (−0.98 mm 2 [−2.45, 0.49]; P = 0.2), change in carotid plaque index was already significantly lower in the NA treated group (−0.016 [−0.03, 0.0019]; P = 0.03). Conclusions: This is the first demonstration that addition of high dose modified-release nicotinic acid, to statin-treated patients with low HDL-C, reduces carotid atherosclerosis at 12 months compared to placebo.
Recognition and Surgical Repair of Superior Mesenteric Arteriovenous Fistula
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Safety of Antidepressant Use in Pregnant and Nursing Women
Authors: L. Lamberg
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Respiratory Failure
Authors: Rudolph H. DE Jong
Journal: JAMA (1977)

Respiratory failure, defined as failure to maintain blood-gas homeostasis, is caused by collapse of one or more of the mechanisms that normally secure gas exchange between air and blood. To understand respiratory failure, one has to know which of the normal respiratory processes is altered or affected; nearly a third of the book is given to the physiology and mechanics of ventilation, gas exchange, and gas transport. The chief remedy for respiratory failure considered here is mechanical ventilation, and the authors provide a complete guide to this mode of therapy. Since the pattern of failure varies with the cause, each medical specialty tends to develop its own therapeutic approach, dictated to a large extent by the immediacy of the process. Drugs and poisons may necessitate remedial action within minutes, whereas ventilatory changes in chronic pulmonary disease can be measured in days. This book attempts to bring these divergent outlooks into
Surgical Care Improvement Project Adherence and Postoperative Infections
Authors: Joseph A. Hyder
Journal: JAMA (2010)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A NONTRADITIONAL VIEW OF HEART FAILURE
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Error in Conclusions
Journal: JAMA Network Open (2020)

Neha S. Gangal, MS; Ana L. Hincapie, PhD; Roman Jandarov, PhD; Stacey M. Frede, PharmD; Jill M. Boone, PharmD; Neil J. MacKinnon, PhD; Kathleen Koechlin, PhD; Jolene DeFiore-Hyrmer, MPH; Amy Holthusen, MPH; Pamela C. Heaton, PhD
Quotation Correction
Authors: Adam Borit
Journal: JAMA (1982)

<h3>To the Editor.—</h3> In their article on Cushing's disease (1981;246:2722), Huldrick Kammer, MD, and Richard George, MD, apparently misquote the article written by Dr Blanshard and myself on a sphenoidal pituitary adenoma. In Table 3, the authors seem to indicate that the patient we described had a pituitary tumor in the sella with a tumor also in the temporal lobe poles and olfactory tract, as well as clinical acromegaly. Review of the article by Dr Blanshard and myself indicates that our patient had a normal sella, with a tumor only in the sphenoid bones, and no acromegaly.
A predictive model of hospitalization and potential cost savings associated with oxandrolone in cancer patients with involuntary weight loss (IWL)
Authors: H. T. Hatoum, A. S. Pickard, F. D. Ottery
Journal: Journal of Clinical Oncology (2004)

8259 Background: Patients (pts) with cancer often experience IWL. Health economics literature is limited and has focused on malnutrition, often co-existant with IWL. Oxandrolone (Oxandrin®) is an anabolic agent indicated for IWL, with demonstrated efficacy and safety in 2 clinical studies in cancer. \(\underline{\mathrm{Objectives:}}\) To (1) develop a model to predict probability of hospitalization in cancer pts based on severity of clinical status; (2) estimate costs associated with this probability of hospitalization at baseline and 2 months (M2) post-treatment with oxandrolone. Methods: Subjects in 2 studies [placebo-controlled (PC), n=65 subjects with upper aerodigestive tract cancer \(\underline{\mathrm{or}}\) open label (OL), n=131 in a variety of cancers] were assessed at baseline and M2 for weight and global clinical status, using the validated Patient-Generated Subjective Global Assessment (PG-SGA) tool. Logistic regression was used to develop a model to predict the probability of hospitalization based on PG-SGA scores. The model was derived from the PC study, and subsequently applied to the OL study with oxandrolone. Rates of hospitalization associated with different PG-SGA scores at treatment inception and at M2 were estimated. Hospitalization costs were projected from mean charges for DRG 296 (nutritional disorders, with chronic condition) from the Healthcare Cost and Utilization Project (HCUP) database. Results: PG-SGA was a significant predictor (p=0.008) of hospitalization (R2=0.25). When applied to patients who completed PG-SGA at M2 (n=83) in the open label study, the model predicted 33.6 hospitalizations for baseline PG-SGA scores, and 17.2 hospitalizations based on scores at M2. Predicted cost savings attributed to oxandrolone in terms of reduced hospitalization was $2,223 per pt. Conclusions: Using a predictive model of hospitalization based on PG-SGA score, predicted cost savings of $2,223 per patient were associated with treatment with oxandrolone. These savings, coupled with the gains in weight and QOL scores that have been associated with oxandrolone, should be considered in treatment decisions for involuntary weight loss. Author Disclosure Employment or Leadership Consultant or Advisory Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Savient Pharmaceuticals, Inc. Savient Pharmaceuticals, Inc.